Biodesix Inc (BDSX): Revenue
$88.50M
Year ended 2025-12-31
$102.94M
Trailing 12 months to 2026-06-30
+32.3%
3-year compound annual growth
+14.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.50M | +24.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $71.32M | +45.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $49.09M | +28.5% | 2025-03-03, From 2023-01-01 |
| 2022-12-31 | $38.21M | -29.9% | 2024-03-01, From 2022-01-01 |
| 2021-12-31 | $54.51M | +19.6% | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | $45.56M | +85.6% | 2022-03-14, From 2020-01-01 |
| 2019-12-31 | $24.55M | n/a | 2021-03-16, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Biodesix Inc (BDSX) | 2025-12-31 | $88.50M | +24.1% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $69.65M | -17.7% |
| Exagen Inc. (XGN) | 2025-12-31 | $66.58M | +19.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $147.17M | +17.2% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $28.08M | -0.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $305.11M | +100.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $322.67M | +13.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $344.23M | +3.7% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $379.81M | +13.8% |
Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗